Primary and Secondary Ethical Issues Arising From the Introduction of Recombinant Factor VIII: "Primum Non Nocere," but What Next?
Transfusion Medicine Reviews. 1992 Oct; 6(4): 271-276.
Alternatives; Beneficence; Biomedical Technologies; Blood; Developing Countries; DNA; Drug Industry; Drugs; Economics; Ethical Analysis; Ethics; Health; Health Care; Health Care Delivery; Health Insurance; Hemophilia; Industry; Injuries; Insurance; Justice; Moral Obligations; Moral Policy; National Health Insurance; Obligations of Society; Patient Care; Patients; Public Policy; Research; Risks and Benefits;
Showing items related by title, author, creator and subject.
What's in a Name for Memory Errors? Implications and Ethical Issues Arising From the Use of the Term "False Memory" for Errors in Memory for Details DePrince, Anne P.; Allard, Carolyn B.; Oh, Hannah; Freyd, Jennifer J. (2004)
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges Duggan, P. S.; Siegel, A. W.; Blass, David M.; Bok, Hilary; Coyle, J. T.; Faden, R.; Finkel, J.; Gearhart, J. D.; Greely, H. T.; Hillis, A.; Hoke, A.; Johnson, R.; Johnston, M.; Kahn, J.; Kerr, D.; King, P.; Kurtzberg, J.; Liao, S. M.; McDonald, J. W.; McKhann, G. (2009-05)The prospect of using cell-based interventions (CBIs) to treat neurological conditions raises several important ethical and policy questions. In this target article, we focus on issues related to the unique constellation ...